However, the percentage of LCN2+ cells among PMN-MDSCs or the number of LCN2+ CD11b+Ly6GhiLy6Clow cells were significantly increased in the tumor after stroke (Figure 5). This evidence concerns the gene LCN2 and stroke disorder.